Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer

This study has been terminated.
(Slow Accrual)
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Aultman Hospital
ClinicalTrials.gov Identifier:
NCT00315211
First received: April 17, 2006
Last updated: October 31, 2007
Last verified: October 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2007
  Estimated Primary Completion Date: No date given